Indo US Bio-Tech Ltd - Stock Valuation and Financial Performance

BSE: 541304 | NSE: | Agriculture | Small Cap

Indo US Bio-Tech Share Price

221.95 25.95 13.24%
as on 28-Mar'24 16:01

DeciZen - make an informed investing decision on Indo US Bio-Tech

Overall Rating
M-Cap below 500cr. High Risk from low Liquidity Bole Toh

1. Quality

2. Valuation

Overvalued

3. Price Trend

Indo US Bio-Tech stock performance -

mw4me loader
P/E Ratio (SA):
61.47
Market Cap:
445.1 Cr.
52-wk low:
90.1
52-wk high:
304

Is Indo US Bio-Tech Ltd an attractive stock to invest in?

1. Is Indo US Bio-Tech Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Indo US Bio-Tech Ltd is a below average quality company.

2. Is Indo US Bio-Tech Ltd undervalued or overvalued?

The key valuation ratios of Indo US Bio-Tech Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Indo US Bio-Tech Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Indo US Bio-Tech Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Indo US Bio-Tech:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Indo US Bio-Tech Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
ROCE % 11.3%17.4%8.2%10.4%20.9%15.7%14%20.4%14.4%13.8%-
Value Creation
Index
-0.20.2-0.4-0.30.50.100.50.00.0-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 14.819.619.124.529.635.539.840.150.161.762
Sales YoY Gr.-32.2%-2.7%28.7%20.9%19.8%12%0.8%24.8%23.4%-
Adj EPS 0.30.50.40.41.51.51.83.52.93.63.6
YoY Gr.-50%-27.1%11.4%292.3%-1.3%15.9%100%-18.3%26.2%-
BVPS (₹) 2.62.83.23.44.89.511.314.821.227.230.6
Adj Net
Profit
0.30.50.40.41.62.22.65.15.27.27
Cash Flow from Ops. 0.50.1-2.60.1-0.9-3.2-0.80.22.90.5-
Debt/CF from Ops. 3.611.7-1.871.5-7.4-2-10.2514.322.1-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 17.2%15.8%15.8%23.4%
Adj EPS 30.9%18.7%27.3%26.2%
BVPS30%41.4%34.1%28.2%
Share Price - 44.7% 145.6% 108.9%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
Return on
Equity %
13.219.811.711.737.223.316.826.917.315.512.5
Op. Profit
Mgn %
2.53.12.75.19.710.11013.813.915.219.8
Net Profit
Mgn %
1.82.51.91.65.36.26.412.710.511.711.7
Debt to
Equity
0.80.61.41.41.30.50.50.50.30.2-
Working Cap
Days
12510117317016118824332231431795
Cash Conv.
Cycle
6548848410214617321425527172

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 15.80%

Net Profit is growing at healthy rate in last 3 years 27.30%

Sales growth is good in last 4 quarters at 22.68%

Return on Equity has declined versus last 3 years average to 12.50%

Latest Financials - Indo US Bio-Tech Ltd.

Standalone Consolidated
TTM EPS (₹) 3.6 2.5
TTM Sales (₹ Cr.) 61.7 50.1
BVPS (₹.) 30.6 0
Reserves (₹ Cr.) 41 29
P/BV 7.27 0.00
PE 61.47 87.90
From the Market
52 Week Low / High (₹) 90.10 / 303.95
All Time Low / High (₹) 12.85 / 303.95
Market Cap (₹ Cr.) 445
Equity (₹ Cr.) 20.1
Face Value (₹) 10
Industry PE 22.6

Management X-Ray of Indo US Bio-Tech:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Indo US Bio-Tech

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Sales15201925303540405062
Operating Expenses 14191923273236354352
Manufacturing Costs11102729294845
Material Costs12171720232240-92
Employee Cost 0000000001
Other Costs 1112222543
Operating Profit 0111334679
Operating Profit Margin (%) 2.5%3.1%2.7%5.1%9.1%9.6%10.0%13.8%13.8%15.2%
Other Income 0000000000
Interest 0001101111
Depreciation 0000000001
Exceptional Items 0000000000
Profit Before Tax 0001233457
Tax 0000110-100
Profit After Tax 0000123557
PAT Margin (%) 1.8%2.5%1.9%1.6%4.9%5.9%6.4%12.7%10.5%11.7%
Adjusted EPS (₹)0.30.50.40.41.41.41.73.52.93.6
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23

Equity and Liabilities

Shareholders Fund 233351416223954
Share Capital 11113566910
Reserves 11222910153044
Minority Interest0000000000
Debt2255658111010
Long Term Debt0000111332
Short Term Debt2144557778
Trade Payables2354528921
Others Liabilities 0000122243
Total Liabilities 671312172435435569

Fixed Assets

Gross Block2222231267
Accumulated Depreciation1111010000
Net Fixed Assets1111211267
CWIP 0000011221
Investments 0000000000
Inventories24556119122327
Trade Receivables21659921252125
Cash Equivalents 0000000000
Others Assets1111012238
Total Assets 671312172435435569

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Cash Flow From Operating Activity 00-30-1-3-1031
PBT 0001233457
Adjustment 0000111122
Changes in Working Capital 0-1-3-1-3-7-5-5-4-9
Tax Paid 0000000000
Cash Flow From Investing Activity 00000-3-1-2-5-7
Capex 00000-10-2-4-2
Net Investments 0000000000
Others 00001-100-1-5
Cash Flow From Financing Activity 0030162126
Net Proceeds from Shares 0000070038
Net Proceeds from Borrowing 00001-1030-2
Interest Paid 0000-10-1-1-1-1
Dividend Paid 0000000000
Others 0030003011
Net Cash Flow 0000000000
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Ratios
ROE (%)13.1919.8311.6911.7434.3622.2116.7426.8717.3415.51
ROCE (%)8.9613.927.3914.2427.8420.3516.6518.315.8614.62
Asset Turnover Ratio2.473.011.881.952.051.741.361.031.021
PAT to CFO Conversion(x)NANNAN-INFNAN-1-1.5-0.3300.60.14
Working Capital Days
Receivable Days633166798793138208165134
Inventory Days4858917870879196128149
Payable Days5647867964544180-223302

Indo US Bio-Tech Ltd Stock News

Indo US Bio-Tech Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Indo US Bio-Tech on 28-Mar-2024 16:01 is ₹221.9.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 28-Mar-2024 16:01 the market cap of Indo US Bio-Tech stood at ₹445.1.
The latest P/E ratio of Indo US Bio-Tech as of 28-Mar-2024 16:01 is 61.47.
The latest P/B ratio of Indo US Bio-Tech as of 28-Mar-2024 16:01 is 7.27.
The 52-week high of Indo US Bio-Tech is ₹303.9 and the 52-week low is ₹90.10.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Indo US Bio-Tech is ₹61.74 ( Cr.) .

About Indo US Bio-Tech Ltd

No data to display
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.